keyword
https://read.qxmd.com/read/38559803/covid-19-impacts-and-inequities-among-underserved-communities-with-diabetes
#1
JOURNAL ARTICLE
Jennifer L Maizel, Michael J Haller, David M Maahs, Ananta Addala, Rayhan A Lal, Stephanie L Filipp, Matthew J Gurka, Sarah Westen, Brittney N Dixon, Lauren Figg, Melanie Hechavarria, Keilecia G Malden, Ashby F Walker
BACKGROUND: People with diabetes have higher COVID-19 morbidity and mortality. These risks are amplified for underserved communities including racial/ethnic minorities and people with lower socioeconomic status. However, limited research has examined COVID-19 outcomes specifically affecting underserved communities with diabetes. METHODS: From November 2021 to July 2022, adults with insulin-requiring diabetes at federally qualified health centers in Florida and California (n = 450) completed surveys examining COVID-19 outcomes and demographics...
June 2024: Journal of Clinical & Translational Endocrinology
https://read.qxmd.com/read/38252849/clinical-prediction-models-combining-routine-clinical-measures-have-high-accuracy-in-identifying-youth-onset-type-2-diabetes-defined-by-maintained-endogenous-insulin-secretion-the-search-for-diabetes-in-youth-study
#2
JOURNAL ARTICLE
Angus G Jones, Beverley M Shields, Richard A Oram, Dana M Dabelea, William A Hagopian, Eva Lustigova, Amy S Shah, Julieanne Knupp, Amy K Mottl, Ralph B D'Agostino, Adrienne Williams, Santica M Marcovina, Catherine Pihoker, Jasmin Divers, Maria J Redondo
OBJECTIVE: With high prevalence of obesity and overlapping features between diabetes subtypes, accurately classifying youth-onset diabetes can be challenging. We aimed to develop prediction models that, using characteristics available at diabetes diagnosis, can identify youth who will retain endogenous insulin secretion at levels consistent with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We studied 2,966 youth with diabetes in the prospective SEARCH for Diabetes in Youth study (diagnosis age ≤19 years) to develop prediction models to identify participants with fasting C-peptide ≥250 pmol/L (≥0...
January 22, 2024: Diabetes Care
https://read.qxmd.com/read/38240246/updating-our-understanding-of-device-use-in-adolescents-demographic-factors-and-preferences-in-a-group-of-adolescents-with-type-1-diabetes
#3
JOURNAL ARTICLE
Sydney Garretson, Angelee Parmar, Randi Streisand, Sarah Jaser, Karishma Datye
PURPOSE: The purpose of the study was to identify demographic factors associated with continuous glucose monitor (CGM) and automated insulin delivery (AID) use among adolescents with type 1 diabetes and to explore why adolescents may start and stop using CGMs. METHODS: Adolescents ages 13 to 17 and caregivers completed demographic and device use surveys at baseline for a randomized trial of a behavioral intervention conducted at 2 large medical centers in the United States...
January 19, 2024: The science of diabetes self-management and care
https://read.qxmd.com/read/37794113/utility-and-precision-evidence-of-technology-in-the-treatment-of-type-1-diabetes-a-systematic-review
#4
JOURNAL ARTICLE
Laura M Jacobsen, Jennifer L Sherr, Elizabeth Considine, Angela Chen, Sarah M Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, Selma Alamarie, Maria J Redondo, Korey K Hood, Peter A Gottlieb, Pieter Gillard, Jessie J Wong, Irl B Hirsch, Richard E Pratley, Lori M Laffel, Chantal Mathieu
BACKGROUND: The greatest change in the treatment of people living with type 1 diabetes in the last decade has been the explosion of technology assisting in all aspects of diabetes therapy, from glucose monitoring to insulin delivery and decision making. As such, the aim of our systematic review was to assess the utility of these technologies as well as identify any precision medicine-directed findings to personalize care. METHODS: Screening of 835 peer-reviewed articles was followed by systematic review of 70 of them (focusing on randomized trials and extension studies with ≥50 participants from the past 10 years)...
October 5, 2023: Commun Med (Lond)
https://read.qxmd.com/read/37709596/association-between-sleep-variability-and-time-in-range-of-glucose-levels-in-patients-with-type-1-diabetes-cross-sectional-study
#5
JOURNAL ARTICLE
Sirimon Reutrakul, Ghada Abu Irsheed, Minsun Park, Alana D Steffen, Larisa Burke, Sarida Pratuangtham, Kelly Glazer Baron, Jennifer Duffecy, Rose Perez, Laurie Quinn, Margaret H Clark Withington, Adam Hussain Saleh, Bernardo Loiacono, Dan Mihailescu, Pamela Martyn-Nemeth
OBJECTIVE: Sleep and circadian disturbances emerge as novel factors influencing glycemic control in type 1 diabetes (T1D). We aimed to explore the associations among sleep, behavioral circadian parameters, self-care, and glycemic parameters in T1D. METHODS: Seventy-six non-shift-working adult T1D patients participated. Blinded 7-day continuous glucose monitoring (CGM) and hemoglobin A1C (A1C) were collected. Percentages of time-in-range (glucose levels 70-180 mg/dL) and glycemic variability (measured by the coefficient of variation [%CV]) were calculated from CGM...
September 12, 2023: Sleep Health
https://read.qxmd.com/read/37605190/newly-diagnosed-type-2%C3%A2-diabetes-does-new-zealand-general-practice-adequately-prepare-patients-to-self-manage-their-condition
#6
JOURNAL ARTICLE
Lynne Chepulis, Jessie Mellsop-Kupe, Suzanne Moorhouse, Rawiri Keenan, Kimberley Norman, Ryan Paul
BACKGROUND: Type 2 diabetes mellitus (T2D) is predominantly managed in primary care, and patients need to be provided with appropriate knowledge and education to understand how to best self-manage their condition. For optimal T2D self-management, primary care teams should share this information from the time of diagnosis. Little is currently known about how and when these resources are being provided to patients with T2D in New Zealand. METHODS: An online survey was carried out between Oct 2022 and Feb 2023...
August 21, 2023: BMC Prim Care
https://read.qxmd.com/read/37306442/prevalence-cost-and-burden-of-diabetic-ketoacidosis
#7
REVIEW
Naunihal Virdi, Yeesha Poon, Richard Abaniel, Richard M Bergenstal
Diabetic ketoacidosis (DKA) is a life-threatening complication, which is most common in individuals with type 1 diabetes (T1D) and is a significant risk for morbidity and mortality, and it is an economic burden on individuals, health care systems, and payers. Younger children, minority ethnic groups, and those with limited insurance are at the greatest risk for presentation of DKA at T1D diagnosis. Although monitoring ketone levels is an essential part of acute illness management and for both early detection and prevention of a DKA episode, studies have reported poor adherence to ketone monitoring...
June 2023: Diabetes Technology & Therapeutics
https://read.qxmd.com/read/37148112/influence-of-prior-internist-encounter-on-glycaemic-control-among-patients-with-type-2-diabetes-mellitus-at-a-family-practice-setting-in-nigeria
#8
JOURNAL ARTICLE
Godpower Chinedu Michael, Bukar Alhaji Grema, Zainab Abdulkadir, Haliru Ibrahim, Abdullah Ibrahim Haruna
BACKGROUND: The huge global diabetes burden and the paucity of diabetes specialists make primary care physicians important stakeholders in controlling diabetes. Hence, we examined the predictors of glycaemic control among primary care patients with type 2 diabetes mellitus (T2DM), highlighting the influence of prior internist encounters during the preceding year on glycaemic control. METHODS: This questionnaire-based cross-sectional study involved 276 T2DM patients systematically recruited from attendees of a general outpatient clinic (GOPC) in Kano, Nigeria...
2023: Nigerian Postgraduate Medical Journal
https://read.qxmd.com/read/37101032/-gestational-diabetes-mellitus-update-2023
#9
JOURNAL ARTICLE
Alexandra Kautzky-Willer, Yvonne Winhofer, Herbert Kiss, Veronica Falcone, Angelika Berger, Monika Lechleitner, Raimund Weitgasser, Jürgen Harreiter
Gestational diabetes (GDM) is defined as any degree of glucose intolerance with onset during pregnancy and is associated with increased feto-maternal morbidity as well as long-term complications in mothers and the offspring. Women detected to have diabetes early in pregnancy receive the diagnosis of overt, non-gestational, diabetes (glucose: fasting ≥ 126 mg/dl, spontaneous ≥ 200 mg/dl or HbA1c  ≥ 6.5% before 20 weeks of gestation). GDM is diagnosed by an oral glucose tolerance test (oGTT) or increased fasting glucose (≥ 92 mg/dl)...
January 2023: Wiener Klinische Wochenschrift
https://read.qxmd.com/read/36785858/gender-associated-cardiometabolic-risk-profiles-and-health-behaviors-in-patients-with-type-2-diabetes-a-cross-sectional-analysis-of-the-joint-asia-diabetes-evaluation-jade-program
#10
JOURNAL ARTICLE
Lee-Ling Lim, Eric S H Lau, Alice P S Kong, Amy W C Fu, Vanessa Lau, Weiping Jia, Wayne H H Sheu, Leorino Sobrepena, K H Yoon, Alexander T B Tan, Yook-Chin Chia, Aravind Sosale, Banshi D Saboo, Jothydev Kesavadev, Su-Yen Goh, Thy Khue Nguyen, Yotsapon Thewjitcharoen, Raymond Suwita, Ronald C W Ma, Elaine Y K Chow, Andrea O Y Luk, Juliana C N Chan
BACKGROUND: In Asia, diabetes-associated death due to cardiorenal diseases were 2-3 times higher in women than men which might be due to gender disparity in quality of care and health habits. METHODS: Adults with type 2 diabetes (T2D) from 11 Asian countries/areas were assessed using the same protocol (2007-2015). We compared treatment target attainment (HbA1c < 7%, blood pressure [BP] < 130/80 mmHg, risk-based LDL-cholesterol, lack of central obesity [waist circumference <90 cm in men or <80 cm in women), use of cardiorenal-protective drugs (renin-angiotensin system [RAS] inhibitors, statins), and self-reported health habits including self-monitoring blood glucose (SMBG) by gender...
March 2023: The Lancet Regional Health. Western Pacific
https://read.qxmd.com/read/36409474/assessment-of-glucose-monitoring-adherence-in-medicare-beneficiaries-with-insulin-treated-diabetes
#11
JOURNAL ARTICLE
Gary A Puckrein, Irl B Hirsch, Christopher G Parkin, Bruce T Taylor, Gregory Norman, Liou Xu, David G Marerro
BACKGROUND: We investigated the potential associations between race/ethnicity and adherence to prescribed glucose monitoring in a sample of Medicare beneficiaries with diabetes and how adherence to the method used impacted diabetes-related inpatient hospitalizations and associated costs among beneficiaries with intensive insulin-treated diabetes. METHODS: This 12-month retrospective analysis utilized Centers for Medicare & Medicare Services (CMS) data to identify Medicare beneficiaries who used intensive insulin therapy from January through December 2018 and classified them into four groups: 1) persons using real-time continuous monitoring (rtCGM), 2) persons using any method of blood glucose monitoring (BGM) who followed prescribed use patterns (adherent), 3) persons who were prescribed BGM but were non-adherent in its use, and 4) no record of any form of BGM...
November 21, 2022: Diabetes Technology & Therapeutics
https://read.qxmd.com/read/35312757/utility-of-diabetes-type-specific-genetic-risk-scores-for-the-classification-of-diabetes-type-among-multiethnic-youth
#12
JOURNAL ARTICLE
Richard A Oram, Seth A Sharp, Catherine Pihoker, Lauric Ferrat, Giuseppina Imperatore, Adrienne Williams, Maria J Redondo, Lynne Wagenknecht, Lawrence M Dolan, Jean M Lawrence, Michael N Weedon, Ralph D'Agostino, William A Hagopian, Jasmin Divers, Dana Dabelea
OBJECTIVE: Genetic risk scores (GRSs) aid classification of diabetes type in White European adult populations. We aimed to assess the utility of GRS in the classification of diabetes type among racially/ethnically diverse youth in the U.S. RESEARCH DESIGN AND METHODS: We generated type 1 diabetes (T1D)- and type 2 diabetes (T2D)-specific GRSs in 2,045 individuals from the SEARCH for Diabetes in Youth study. We assessed the distribution of genetic risk stratified by diabetes autoantibody positive or negative (DAA+/-) and insulin sensitivity (IS) or insulin resistance (IR) and self-reported race/ethnicity (White, Black, Hispanic, and other)...
March 21, 2022: Diabetes Care
https://read.qxmd.com/read/35019844/use-of-health-information-technology-by-adults-with-diabetes-in-the-united-states-cross-sectional-analysis-of-national-health-interview-survey-data-2016-2018
#13
JOURNAL ARTICLE
Seamus Y Wang, Hsin-Chieh Yeh, Arielle Apfel Stein, Edgar R Miller
BACKGROUND: The use of health information technology (HIT) has been proposed to improve disease management in patients with type 2 diabetes mellitus. OBJECTIVE: This study aims to report the prevalence of HIT use in adults with diabetes in the United States and examine the factors associated with HIT use. METHODS: We analyzed data from 7999 adults who self-reported a diabetes diagnosis as collected by the National Health Interview Survey (2016-2018)...
January 12, 2022: JMIR Diabetes
https://read.qxmd.com/read/34728528/the-impact-of-racial-and-ethnic-health-disparities-in-diabetes-management-on-clinical-outcomes-a-reinforcement-learning-analysis-of-health-inequity-among-youth-and-young-adults-in-the-search-for-diabetes-in-youth-study
#14
JOURNAL ARTICLE
Anna R Kahkoska, Teeranan Pokaprakarn, G Rumay Alexander, Tessa L Crume, Dana Dabelea, Jasmin Divers, Lawrence M Dolan, Elizabeth T Jensen, Jean M Lawrence, Santica Marcovina, Amy K Mottl, Catherine Pihoker, Sharon H Saydah, Michael R Kosorok, Elizabeth J Mayer-Davis
OBJECTIVE: To estimate difference in population-level glycemic control and the emergence of diabetes complications given a theoretical scenario in which non-White youth and young adults (YYA) with type 1 diabetes (T1D) receive and follow an equivalent distribution of diabetes treatment regimens as non-Hispanic White YYA. RESEARCH DESIGN AND METHODS: Longitudinal data from YYA diagnosed 2002-2005 in the SEARCH for Diabetes in Youth Study were analyzed. Based on self-reported race/ethnicity, YYA were classified as non-White race or Hispanic ethnicity (non-White subgroup) versus non-Hispanic White race (White subgroup)...
November 2, 2021: Diabetes Care
https://read.qxmd.com/read/34546086/health-care-disparities-in-use-of-continuous-glucose-monitoring
#15
JOURNAL ARTICLE
Diana Isaacs, Natalie J Bellini, Ursula Biba, Albert Cai, Kelly L Close
Numerous studies have demonstrated that use of continuous glucose monitoring (CGM) improves glycemic control and reduces diabetes-related hospitalizations and emergency room service utilization in individuals with diabetes who are treated with intensive insulin regimens. Recent studies have revealed disparities in use of CGM within racially and ethnically diverse and lower socioeconomic populations, leading to underutilization of CGM in these populations. This article reviews the scope and impact of these disparities on utilization of CGM and explores the factors that may be contributing to this issue...
September 2021: Diabetes Technology & Therapeutics
https://read.qxmd.com/read/33282686/effect-of-depression-on-diabetes-self-care-in-type-2-diabetes-patients-at-a-saudi-teaching-hospital-a-cross-sectional-study
#16
JOURNAL ARTICLE
Ranya Alawy Ghamri, Maryam Abdulhamid Jabali
Aim: This study aimed to assess the relationship between depression and diabetes, especially with regard to diabetes self-care, treatment compliance, and preventive care. Materials and Methods: This is a cross-sectional survey of adult diabetes patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia. The Patient Health Questionnaire-9 was used to assess depression. Results: A total of 346 patients were included: 266 (77%) women and 80 (23%) men...
July 2020: Journal of Microscopy and Ultrastructure
https://read.qxmd.com/read/33155826/racial-ethnic-disparities-in-diabetes-technology-use-among-young-adults-with-type-1-diabetes
#17
JOURNAL ARTICLE
Shivani Agarwal, Clyde Schechter, Jeffrey Gonzalez, Judith A Long
BACKGROUND: Recent studies highlight racial-ethnic disparities in insulin pump and continuous glucose monitor (CGM) use in people with type 1 diabetes (T1D), but drivers of disparities remain poorly understood beyond socioeconomic status (SES). METHODS: We recruited a diverse sample of young adults (YA) with T1D from six diabetes centers across the U.S., enrolling equal numbers of Non-Hispanic (NH) White, NH Black, and Hispanic YA. We used multivariate logistic regression to examine to what extent SES, demographics, healthcare factors (care setting, clinic attendance) and diabetes self-management (diabetes numeracy, self-monitoring of blood glucose, and self-care inventory score) explained insulin pump and CGM use in each racial-ethnic group...
November 6, 2020: Diabetes Technology & Therapeutics
https://read.qxmd.com/read/33154039/effects-of-a-tailored-text-messaging-intervention-among-diverse-adults-with-type-2-diabetes-evidence-from-the-15-month-reach-randomized-controlled-trial
#18
JOURNAL ARTICLE
Lyndsay A Nelson, Robert A Greevy, Andrew Spieker, Kenneth A Wallston, Tom A Elasy, Sunil Kripalani, Chad Gentry, Erin M Bergner, Lauren M LeStourgeon, Sarah E Williamson, Lindsay S Mayberry
OBJECTIVE: Text messaging interventions have high potential for scalability and for reductions in health disparities. However, more rigorous, long-term trials are needed. We examined the long-term efficacy and mechanisms of a tailored text messaging intervention. RESEARCH DESIGN AND METHODS: Adults with type 2 diabetes participated in a parallel-groups, 15-month randomized controlled trial and were assigned to receive Rapid Education/Encouragement and Communications for Health (REACH) for 12 months or control...
November 5, 2020: Diabetes Care
https://read.qxmd.com/read/32886192/impact-of-a-comprehensive-digital-health-programme-on-hba-1c-and-weight-after-12-months-for-people-with-diabetes-and-prediabetes-a-randomised-controlled-trial
#19
JOURNAL ARTICLE
Melissa McLeod, James Stanley, Virginia Signal, Jeannine Stairmand, Donna Thompson, Kelly Henderson, Cheryl Davies, Jeremy Krebs, Anthony Dowell, Rebecca Grainger, Diana Sarfati
AIMS/HYPOTHESIS: The aim of this RCT was to evaluate the effectiveness of a digital health programme (BetaMe/Melon) vs usual care in improving the control of type 2 diabetes and prediabetes in a primary care population. METHODS: We conducted a randomised parallel-group two-arm single-blinded superiority trial in the primary care setting in two regions of New Zealand. Eligible participants were identified through Primary Health Organisations and participating practices...
September 4, 2020: Diabetologia
https://read.qxmd.com/read/32107264/high-prevalence-of-impaired-awareness-of-hypoglycemia-and-severe-hypoglycemia-among-people-with-insulin-treated-type-2-diabetes-the-dutch-diabetes-pearl-cohort
#20
JOURNAL ARTICLE
Lian A van Meijel, Femmie de Vegt, Evertine J Abbink, Femke Rutters, Miranda T Schram, Melanie M van der Klauw, Bruce H R Wolffenbuttel, Sarah Siegelaar, J Hans DeVries, Eric J G Sijbrands, Behiye Özcan, Harold W de Valk, Bianca Silvius, Nicolaas Schaper, Coen D A Stehouwer, Petra J M Elders, Cornelis J Tack, Bastiaan E de Galan
OBJECTIVE: People with type 2 diabetes on insulin are at risk for hypoglycemia. Recurrent hypoglycemia can cause impaired awareness of hypoglycemia (IAH), and increase the risk for severe hypoglycemia. The aim of this study was to assess the prevalence and determinants of self-reported IAH and severe hypoglycemia in a Dutch nationwide cohort of people with insulin-treated type 2 diabetes. RESEARCH DESIGN AND METHODS: Observational study of The Dutch Diabetes Pearl, a cohort of people with type 2 diabetes treated in primary, secondary and tertiary diabetes care centers...
February 2020: BMJ Open Diabetes Research & Care
keyword
keyword
72316
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.